Your browser doesn't support javascript.
loading
Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer.
Khurana, Namrata; Kim, Hogyoung; Chandra, Partha K; Talwar, Sudha; Sharma, Pankaj; Abdel-Mageed, Asim B; Sikka, Suresh C; Mondal, Debasis.
Afiliação
  • Khurana N; Department of Urology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
  • Kim H; Department of Urology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
  • Chandra PK; Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
  • Talwar S; Department of Urology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
  • Sharma P; Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh 201313, India.
  • Abdel-Mageed AB; Department of Urology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
  • Sikka SC; Department of Urology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
  • Mondal D; Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Oncol Rep ; 38(5): 2774-2786, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28901514

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Receptores Androgênicos / Isotiocianatos / Neoplasias de Próstata Resistentes à Castração Limite: Humans / Male Idioma: En Revista: Oncol Rep Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Receptores Androgênicos / Isotiocianatos / Neoplasias de Próstata Resistentes à Castração Limite: Humans / Male Idioma: En Revista: Oncol Rep Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos